Literature DB >> 14515098

New medical management techniques for acute exacerbations of chronic rhinosinusitis.

Keith J Wahl1, Alan Otsuji.   

Abstract

In the past 2 years, intranasal nebulized medications have emerged as a widely prescribed treatment for medical management of chronic rhinosinusitis. This represents an innovative and advanced approach to treating acute exacerbations of chronic rhinosinusitis topically. The use of specially formulated medication compounds delivered by unique nebulization equipment is reviewed in the treatment of patients with chronic sinus disease. Scientific data including related upper and lower respiratory literature is included, as well as the important aspects of factors affecting nebulized medication delivery to the sinuses. The benefits, effectiveness, risks, and adverse effects of intranasal nebulized medications are also addressed. A treatment algorithm identifying appropriate use of nebulized medications in the treatment plan for chronic sinusitis patients is then presented in diagrammatic format.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515098     DOI: 10.1097/00020840-200302000-00006

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Nebulization of Antibiotics in Management of Sinusitis.

Authors:  Winston C. Vaughan
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

2.  Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status.

Authors:  J R Kuiper; A G Hirsch; K Bandeen-Roche; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; W F Stewart; B S Schwartz
Journal:  Allergy       Date:  2018-02-07       Impact factor: 13.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.